Crypto Stocks Are Heating Up
At the center of this transformation is a game-changing platform that's experiencing explosive growth with $41 million in revenue in just nine months. The stock has doubled in the last 45 days, but this is only the beginning.
Financials
| Curr Year EPS Estimate | -6.17 |
| Next Quarter EPS Estimate | -1.36 |
| Profit Margin | -106.93% |
| Operating Margin | -102.49 |
| Return on Assets | -0.24 |
| Return on Equity | -2.90 |
| Revenue | 522.8M |
| Earnings Per Share | -6.35 |
| Revenue Per Share | 6.02 |
| Gross Profit | -197,588,992 |
| Quarterly Revenue Growth | 0.42 |
General
| Name | Ultragenyx Pharmaceutical Inc |
| Ticker | RARE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,276 |
About Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
Earnings
FireAid, with Billie Eilish and Lady Gaga, is the latest in a long line of massive benefit concerts
Billie Eilish, Sting, Red Hot Chili Peppers and others in a efforts, is the latest event to combine music and philanthropy.
Trump White House Blames 'Outage' For Medicaid Website Lockout: 'We Have Confirmed No Payments Have Been Affected'
On Tuesday January 28, 2025, a federal health payment system lockout, blamed on an "outage," sparked criticism amid Trump's spending freeze, though payments were reportedly unaffected, according to the white house.
Love or Hate Him -- You Have To See What Elon Could Do Next - Ad
It's not electric vehicles, green energy or space travel that Elon Musk will be remembered for.
Stock market today: Asia shares mostly rise while some regional markets stay closed for holidays
TOKYO (AP) — Asian shares mostly rose Thursday after the U.S. Federal Reserve opted for the first time since it began trying to help through easier rates in September.
Apple Surprises Users With Starlink Beta, Teams Up With Elon Musk's SpaceX And T-Mobile To Bring Satellite Texting For iPhone Users In iOS 18.3
Apple has partnered with SpaceX and T-Mobile to bring Starlink satellite texting to iPhones, with a limited beta test rolling out via iOS 18.3, marking a major step toward expanding connectivity in remote areas.
Ex CIA Predicts 40% "Double Crash" -- April 11 - Ad
I strongly advise taking action ahead of this NEW kind of economic crash... What makes this new crash so uniquely dangerous is that it could erase bank accounts.... My best followers are already following the steps laid out in this video. Prepare now, or suffer when the market implodes by 40% in a single day as soon as April 11. You've been warned.
F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside
F5 Inc (NASDAQ: FFIV) reported strong Q1 results, beating revenue and EPS estimates. The stock gained as analysts raised price targets and expectations for further growth from IT budgets, data center refresh, and AI demand.
AI ETFs In Focus As Alibaba Challenges DeepSeek With New Model
AI arms race fueled by DeepSeek and Alibaba's AI models. Investors can profit from trend with AI-focused ETFs, including AIQ, ARKQ, QQQ.
Elon's Next Millionaire-Making Project? - Ad
This could create more wealth than all of his previous ventures... combined.
What to know about Trump's buyout proposal for federal employees
President Donald Trump's administration is offering to federal employees to quickly reduce the government workforce. They don't have a long time to decide: The deadline is Feb. 6.
Despite chaos over Trump White House's funding pause, FAFSA forms and student loans still available
A temporary freeze imposed briefly this week by the White House on federal grants and loans left many students wondering about the impact to the used to apply for financial aid.
How to Invest in Trump's Crypto Revolution with Just $25 - Ad
Since Donald Trump was elected, Bitcoin has soared to over $104,000. That's a six-figure price tag -- PER COIN! But there's a much less expensive -- and better way to take advantage of Trump's crypto revolution. I'm talking about a way to make huge gains with just $25. But you need to be fast.
Hawaii wildfire victims spared from testifying after last-minute deal over $4B settlement
HONOLULU (AP) — Lawyers representing victims of a deadly Hawaii wildfire reached a last-minute deal averting a trial Wednesday to determine how to split a .
Wall Street's Most Accurate Analysts Weigh In On 3 Consumer Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
Top-Secret Military Base in New Mexico Desert - Ad
Out in the New Mexico desert sits a top secret government facility... The scientists here are studying a new technology that will change the way wars are fought... Once you see this thing for yourself -- you'll know in your heart it could be coming for all of us. That's why I've taken steps to help protect myself and my family from what could be unleashed as early as April 11.
Datadog Faces Revenue And Margin Headwinds In 2025, Analyst Downgrades Stock
Stifel analyst Brad Reback downgraded Datadog from Buy to Hold and lowered its price target to $140, citing concerns over modest growth despite a contract renewal with OpenAI.
Donald and Melania Trump Memecoins Outgain Bitcoin, Ethereum Amid Market Lull -- Analyst Says TRUMP Bottomed Out At $25
President Donald Trump‘s meme coin outperformed the broader cryptocurrency market with a double-digit surge on Monday. What happened: The Official Trump (TRUMP) token surged over 10% in the last 24 hours, reaching a market valuation of $5.92 billion and a fully diluted value of $29.62 billion.
Stunning Trump Exec Order Leaked - Ad
This secret document contains stunning details about Donald Trump's big Day 1 announcement... His allies are calling it Trump's Secret Manhattan Project. Because if what's in this leaked document is even half true (and trust me, it comes from a very, very credible source)... It will be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. And over the next 100 days, it could set off a huge dose of "Trump Market Euphoria"... igniting a buying frenzy in very specific AI stocks... unlike anything we've seen so far.
Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.
Profiting from Wildfires and Hurricanes - Ad
From California's wildfires to Florida's hurricanes, this company is cashing in on disaster recovery contracts. With a $15-$35M deal and soaring scrap metal demand, they're poised for growth.
7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape
The launch of DeepSeek affects the AI boom including the power, cooling and data center giants that once rode the AI euphoria, which now have single-day losses exceeding 20%.
UK Faces Triple Threat as Economic Uncertainty Hits
The United Kingdom faces a decline in stock market listings, demographic crisis, and diminishing tax revenue with an exodus of high earners.
Elon Musk's Critical Metals Warning: What Investors Need to Know - Ad
Elon Musk has repeatedly warned about the looming critical metals crisis, calling materials like nickel, copper, and PGMs essential to Tesla's future. One Canadian discovery in Quebec is drawing comparisons to Russia's Norilsk Mine and has the potential to reshape global supply chains. With heavyweight backers and a fully funded exploration plan, this opportunity demands attention.
Robert Kiyosaki Predicts Yet Another Stock Market Crash, Pitches Bitcoin Investments — Here's What The 'Rich Dad Poor Dad' Author Said
Renowned investor and author Robert Kiyosaki on Monday predicted a major stock market crash in February and advised investors to focus on Bitcoin (CRYPTO: BTC), gold, and silver.
Microsoft reports 10% quarterly profit growth as it works to show AI investments paying off
REDMOND, Wash. (AP) — Microsoft Corp. said Wednesday that its profit for the October-December quarter grew 10% from the same time last year as it works to capitalize on the huge amounts of money it has spent to advance its artificial intelligence technology.
The Stock Rebuilding America - Ad
Wildfires and hurricanes wreaked havoc, but one company is turning debris into dollars.
Lyft Faces Growing Competition, Bank of America Analyst Warns
Bank of America analyst Micheal McGovern reiterated a Buy rating on Lyft and lowered the price target from $21 to $19.
Cathie Wood Dumps Tesla Stock Ahead Of Q4 Earnings, Ark Invest Loads Up On Amazon
On Tuesday, Jan. 28, 2025 Cathie Wood-led Ark Invest sold shares of Tesla ahead of its fourth-quarter earnings. Wood purchased Amazon shares on the same day.
Crypto Stocks Surge Amid Market Boom - Ad
Crypto stocks are on fire as Bitcoin hits all-time highs. One under-the-radar company is leading the charge, managing $2.1 billion in client assets and seeing record trading volumes. With crypto adoption skyrocketing, this could be a game-changing opportunity.
Trump Meme Coin Rebounds 9%, Traders See Positive Signs
The Trump (CRYPTO: TRUMP) meme coin has surged into the spotlight, rebounding by 9% on Tuesday.
A South Florida luxury condo project is planned for site where building collapse killed 98 people
SURFSIDE, Fla. (AP) — A Dubai-based developer plans to build a 12-story luxury condominium project on the South Florida site where in 2021, killing 98 people.
The DOGE Agenda (Eight Stocks to Buy) - Ad
Every investor in America is trying to figure out what Musk will do in Washington, D.C. in the coming weeks.
Amid Nvidia And Chinese AI Anxieties, Top Analyst Predicts Higher AI Infrastructure Demand Despite Market Jitters: 'The Market Is Overreacting To DeepSeek's Success'
Nvidia's stock plummeted as China's DeepSeek gained attention for its cost-efficient AI models, but analyst Gene Munster argued the market is overreacting, predicting increased AI infrastructure investment driven by the potential for achieving artificial general intelligence.
Elon Musk's X partners with Visa on payment service in an effort to become an 'everything app,'
NEW YORK (AP) — X is teaming up with Visa to soon offer a system for real-time payments on the social media platform — signaling some progress in a yearslong vision from billionaire owner Elon Musk
Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad
This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.
Trump Memo Heard Around The World: How US Economy Could Adjust To Buyouts For Federal Workers
The Trump administration is offering federal workers a resignation program, causing concern that loyalists will replace them. Potential impacts on economy.
Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity
Fed expected to keep rates steady, but Wall Street desperate for clarity on when next cut will come. Markets hoping for a dovish signal, but Powell may not deliver. Odds of two cuts in 2025 at 93%, with $4 payout for single cut and $6 for no cuts.
Legendary Investor: Buy These "Trump Stocks" Now - Ad
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
Coca-Cola issues safety recall of soft drinks in Europe over chemical chlorate concerns
BRUSSELS (AP) — Coca-Cola has recalled some of its soft drinks in Europe after higher-than-normal levels of a chemical called chlorate were detected in bottles and cans at a production plant in Belgium.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.